Which interventions may yield the biggest health and economic impacts on cardiovascular disease (CVD) in Brazil? This issue briefing assesses the impact of two different, yet complementary, CVD reduction strategies.
Reducing the Burden of Cardiovascular Disease in Brazil
Reducing the Burden of Cardiovascular Disease in Brazil
$0.00
Heart attacks and strokes are common complications of cardiovascular disease (CVD). They happen more often in people with specific risk factors, such as smoking or type 2 diabetes. People with a history of CVD or who suffer from a genetic predisposition to high cholesterol levels are particularly vulnerable to heart attacks and strokes. By reaching World Health Organization risk factor reduction targets, Brazil could gain US$28.5 billion in health care cost and productivity savings between 2016 and 2035 and could also save up to US$43.8 billion by helping high-risk groups lower their cholesterol levels.
Faced with rising health expenditures and an aging population, policy-makers need to act urgently. There is uncertainty, however, around which interventions may yield the biggest health and economic impacts. Reducing the Burden of Cardiovascular Disease in Brazil fills in some of this knowledge by assessing the impact of two very different, yet complementary, CVD reduction strategies.
Effective January 26, 2026, AERIC Inc./Signal49 Research discontinued use of ‘The Conference Board of Canada’ name, logo and branding, which had been used by AERIC Inc./Signal49 Research under license from The Conference Board, Inc. The Conference Board, Inc. and its licensees, which are not affiliated with Signal49 Research, own all right, title and interest in THE CONFERENCE BOARD name and trademarks in Canada and have the exclusive right to their use in Canada since January 26, 2026.
